GATA1-deficient human pluripotent stem cells generate neutrophils with improved antifungal immunity that is mediated

Andrew S Wagner1, Frances M Smith1, David A Bennin2

  • 1Department of Medical Microbiology and Immunology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, United States of America.

Plos Pathogens
|February 3, 2025
PubMed

Insights

Human induced pluripotent stem cell-derived neutrophils (iNeutrophils) lacking GATA1 show enhanced antifungal activity against Aspergillus fumigatus. These modified neutrophils exhibit improved maturation and effector functions, offering a new model for studying fungal immunity.

Area of Science:

  • Immunology
  • Stem Cell Biology
  • Mycology

Background:

  • Neutrophils are crucial for combating fungal infections but are challenging to study due to their short lifespan and limited genetic manipulation.
  • Human induced pluripotent stem cell-derived neutrophils (iNeutrophils) offer a promising, genetically tractable alternative for studying neutrophil function.
  • Understanding neutrophil-fungal interactions is vital for developing effective antifungal therapies.

Purpose of the Study:

  • To investigate the role of the transcription factor GATA1 in human neutrophil antifungal immunity using iPSCs.
  • To characterize the antifungal activity and metabolic responses of GATA1-knockout (KO) iNeutrophils.
  • To elucidate the specific functions of CD18 in GATA1-KO iNeutrophil-mediated defense against Aspergillus fumigatus.

Main Methods:

  • Generation of human induced pluripotent stem cells (iPSCs) with GATA1 deletion.
  • Differentiation of iPSCs into iNeutrophils and comparison with wild-type iNeutrophils.
  • Assessment of iNeutrophil maturation, receptor expression, effector functions, and metabolic pathways (e.g., pentose phosphate pathway) upon fungal stimulation.
  • Functional assays evaluating the killing of Aspergillus fumigatus by GATA1-KO iNeutrophils, including CD18 deletion studies.

Main Results:

  • GATA1-KO iNeutrophils demonstrated enhanced antifungal activity against Aspergillus fumigatus compared to wild-type iNeutrophils.
  • GATA1-KO iNeutrophils exhibited increased maturation, higher expression of antifungal pattern recognition receptors, and improved effector functions.
  • iNeutrophils stimulated with fungal β-glucan shifted metabolism to the pentose phosphate pathway (PPP), mirroring primary human neutrophils.
  • CD18 deletion impaired the killing of Aspergillus fumigatus by GATA1-KO iNeutrophils but did not affect the metabolic shift to the PPP.

Conclusions:

  • GATA1-knockout iNeutrophils represent a valuable and genetically tractable model for studying human neutrophil antifungal immunity.
  • GATA1 deficiency enhances neutrophil maturation and effector functions, leading to improved antifungal capabilities.
  • CD18 plays a role in the direct killing of Aspergillus fumigatus by iNeutrophils, while the metabolic response to fungal components is independent of CD18.